is semaglutide on shortage list FDA Ends Listing, Contributing to Ongoing Legal Challenges US judge upholds FDA's removal
Description
Retatrutide emerges as a promising multi-pathway therapeutic, attracting significant clinical interest for its potent effects on weight loss and metabolic control
Life expectancy slightly reduced (complications like infections)
Clinician-supervised GLP-1 weight loss with semaglutide and tirzepatide
Type 2 diabetes mellitus (T2DM) is a major risk factor for cardiovascular disease
For years, GLP-1 medication has transformed conversations around weight loss but left many virtually locked out by costs
